Lifeway Foods Reports 20% Increase in Q3-To-Date Net Sales, Reaches $39.1 Million Mark

Reuters
Sep 02
Lifeway Foods Reports 20% Increase in Q3-To-Date Net Sales, Reaches $39.1 Million Mark

Lifeway Foods Inc. has announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter through August 31, 2025. This figure represents a 20% increase compared to the same period last year, driven by strong consumer demand for Lifeway's flagship product, Lifeway Kefir, and the expanding Lifeway Farmer Cheese line. CEO Julie Smolyansky highlighted the growth as a reflection of the company's innovation and execution strategies. As Lifeway continues to lead the kefir category, the company is on track to deliver another strong quarter, reinforcing its position in the probiotic nutrition market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeway Foods Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-006605), on September 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10